Intravenous injection of nonselective antagonists of opioid receptors (OR) naltrexone (5 mg/kg) and naloxone methiodide (5 mg/kg), selective δ1-OR antagonist BNTX (0.7 mg/kg), selective δ2-OR blocker naltriben (0.3 mg/kg), selective κ-OR antagonist norbinaltorphimine (2 mg/kg), and selective blocker of ORL1 opioid receptors JTC-801 (0.1 mg/kg) produced no effect on reperfusion injury to the heart in rats narcotized with α-chloralose. In contrast, selective μ-OR antagonist CTAP (1 mg/kg) limited the infarct size, although this effect was not observed at a lower CTAP concentration of 0.1 mg/kg. Probably, the myocardial infarct size-limiting effect of CTAP was associated with activation of the non-opioid receptors. It was hypothesized that endogenous OR agonists did not affect heart resistance to reperfusion injury in unadapted rats.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lishmanov IB, Maslov LN, Naumova AV, Bogomaz SA. μ-Opiate receptor activation and increase in heart resistance to ischemic and reperfusion injury. Ross. Fiziol. Zh. 1998;84(11):1223-1230.
Guo HT, Zhang RH, Zhang Y, Zhang LJ, Li J, Shi QX, Wang YM, Fan R, Bi H, Yin W, Pei JM. Endogenous κ-opioid peptide mediates the cardioprotection induced by ischemic postconditioning. J. Cardiovasc. Pharmacol. 2011;58(2):207-215.
Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Postconditioning prevents reperfusion injury by activating deltaopioid receptors. Anesthesiology. 2008;108(2):243-250.
Ludvigsen E, Carlsson C, Tiensuu Janson E, Sandler S, Stridsberg M. Somatostatin receptor 1-5; expression profiles during rat development. Ups. J. Med. Sci. 2015;120(3):157-168.
Maslov LN, Khaliulin I, Oeltgen PR, Naryzhnaya NV, Pei JM, Brown SA, Lishmanov YB, Downey JM. Prospects for creation of cardioprotective and antiarrhythmic drugs based on opioid receptor agonists. Med Res Rev. 2016;36(5):871-923.
Maslov LN, Lishmanov YB, Oeltgen PR, Barzakh EI, Krylatov AV, Govindaswami M, Brown SA. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury. Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system. Life Sci. 2009;84(19-20):657-663.
Maslov LN, Naryzhnaia NV, Tsibulnikov SY, Kolar F, Zhang Y, Wang H, Gusakova AM, Lishmanov YB. Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia. Life Sci. 2013;93(9-11):373-379.
Murphy DB, Murphy MB. Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism. J. Cardiovasc. Pharmacol. 1999;33(1):122-125.
Neckár J, Sźárszoi O, Herget J, Ostádal B, Kolár F. Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia. Physiol. Res. 2003;52(2):171-175.
Romano MA, McNish R, Seymour EM, Traynor JR, Bolling SF. Differential effects of opioid peptides on myocardial ischemic tolerance. J. Surg. Res. 2004;119(1):46-50.
Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J. Mol. Cell. Cardiol. 1997;29(8):2187-2195.
Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 2007;81(15):1223-1237.
Yamada H, Nakamoto H, Suzuki Y, Ito T, Aisaka K. Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801. Br. J. Pharmacol. 2002;135(2):323-332.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 7, pp. 25-28, July, 2017
Rights and permissions
About this article
Cite this article
Gorbunov, A.S., Vaizova, O.E., Belousov, M.V. et al. Role of Endogenous Agonists of Opioid Receptors in the Regulation of Heart Resistance to Postischemic Reperfusion Injury. Bull Exp Biol Med 164, 18–20 (2017). https://doi.org/10.1007/s10517-017-3916-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3916-6